With Lab facilties in Los Alamos, Specifica is organized around providing the next generation of human antibody engineering and discovery solutions. The firm's discovery technology platform can deliver high-affinity human antibodies with requested characteristics while their native human libraries can provide powerful and exclusive in-house discovery capabilities. The firm offers custom human antibody discovery programs, as well as humanization and affinity maturation services. Specifica's current antibody selection platform has produced highly-specific antibodies to hundreds of targets, many with nano-molar and sub-nano-molar affinities. The firm offers a highly diverse natural antibody libraries that can be accessed on a non-exclusive or fully-exclusive basis, as well as complementary selection methodologies and materials.
